Pharvaris expects pivotal HAE study data in third quarter 2026

Go back to Pharvaris expects pivotal HAE study data in third quarter 2026
(NASDAQ: PHVS) Delayed: 33.19 --0 (-0%)
Previous Close $33.19    52 Week High
Open $33.19    52 Week Low
Day High $33.19    P/E N/A 
Day Low $33.19    EPS
Volume